Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
16.84
+0.41 (2.50%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $720.77 million as of August 7, 2026. Its market cap has increased by 235.17% in one year.
Market Cap
720.77M
Enterprise Value
550.61M
1-Year Change
235.17%
Ranking
Category
Stock Price
$16.84
ChartMarket Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $720.77M, an increase of 133.42%. That is a compound annual growth rate of 110.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 720.77M | 210.87% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 753.25M |
| Rigel Pharmaceuticals | 750.37M |
| BridgeBio Oncology Therapeutics | 747.40M |
| Gyre Therapeutics | 743.63M |
| Cybin | 719.64M |
| AgomAb Therapeutics NV | 714.10M |
| Neurogene | 711.19M |
| Allogene Therapeutics | 693.76M |